Good News! The construction of Yuanpin Bio-innovation Platform was supported by special policy funds from Changsha Economic Development Zone!

Release time:2025-05-16 Form:Home Site

Recently, Changsha Economic and Technological Development Zone (CEDZ) announced the list of enterprises to be supported by the special policy fund for industrial development in the year of 2024, and Yuanpin Bio has been successfully selected to receive the policy fund support by virtue of its excellent innovation platform construction achievements.



As a leading enterprise in the field of stem cells and regenerative medicine in China, Yuanpin Bio has always been adhering to the tenet of “all for the sake of human life and health”, and has deeply ploughed into the layout of the whole cell industry chain. The company invested in the construction of the Zhongnan Yuanpin Stem Cell Science and Technology Park, constructed from the cell storage, technology research and development to the clinical transformation of the whole chain of innovation platforms, including the national stem cell transformation resource base sub-base, Hunan Province, stem cells and translational medicine engineering technology research center and other provincial-level scientific research platforms. The innovation platform construction project supported this time further highlights its benchmark position in basic research, key technology research and industrialization application. 


▲ South Central Source Products Stem Cell Science and Technology Park


Behind the policy support is the continuous technological breakthrough of Yuanpin Bio: 


Scientific research innovation leads the industry: the company cooperates with Guangdong Medical University and Shanghai Changhai Hospital in the clinical research projects of stem cell treatment of diabetic foot and premature ovarian failure, etc., which have passed the national record; the world's first drug independently developed from human amniotic membrane stem cells has been approved by IND, targeting the Acute Respiratory Distress Syndrome (ARDS), which fills in the domestic gaps; Recently, the newly added indications for Chronic Obstructive Pulmonary Disease (COPD) have been approved by IND again. 


Fruitful results of platform construction: the Science and Technology Park is equipped with a cell drug pilot production workshop, completing a comprehensive cell industrialization platform integrating research and development, pilot production, production and technical services, thus further constructing a “research-transformation-incubation-acceleration” full-cycle industrial high-quality development. “thus further building an innovation engine for the high-quality development of the whole cycle of industry. 


Ecological layout of the whole industrial chain: In the future, the company will also plan to build a bio-economy ecological cluster, covering the fields of pharmaceuticals, devices, health management, etc., to help the high-quality development of regional industries. 



Under the guidance of 'three high and four new' strategy, Changsha Economic Development Zone has built an accelerating runway for innovation breakthroughs with a business environment of full-factor escort and full-cycle service for enterprises, and we will repay this trust with technological research. The award will be used to deepen the innovation platform level, accelerate the clinical transformation and industrialization process, and at the same time, relying on the policy advantages of the FTZ, to promote the clinical application of stem cell technology for early and pilot implementation, and to contribute to the global life and health cause of “China's solution”. In the future, Yuanpin Bio will take innovation as the engine and policy as the fulcrum, continue to forge new productivity in biotechnology, and help Changsha Economic and Technological Development Zone to build a first-class scientific and technological innovation highland in China!